Chernobyl Forum EGH3 NonCancer Diseases - PowerPoint PPT Presentation

About This Presentation
Title:

Chernobyl Forum EGH3 NonCancer Diseases

Description:

Chernobyl Forum EGH3 NonCancer Diseases – PowerPoint PPT presentation

Number of Views:75
Avg rating:3.0/5.0
Slides: 55
Provided by: FredMe7
Learn more at: http://www-ns.iaea.org
Category:

less

Transcript and Presenter's Notes

Title: Chernobyl Forum EGH3 NonCancer Diseases


1
Chernobyl ForumEGH-3 Non-Cancer Diseases
  • September 6,7, 2005
  • Vienna International Center

2
EGH-3 Committee
  • M. Balonov, IAEA
  • V. Bebeshko, Ukraine
  • E. Bromet, USA
  • Z. Carr, WHO
  • F. Darroudi, Netherlands
  • J. Havenaar, Netherlands
  • J. Hendry, IAEA
  • E. Kapitonova, Belarus
  • N. Korol, Ukraine
  • V. Ivanov, Russia
  • F. Mettler, USA
  • K. Neriishi, Japan
  • Y. Shibata, Japan
  • G. Souchkevtich, Russia
  • S. Yamashita, WHO
  • B. Worgul, USA

3
1991
1996
1996
4
UNSCEAR 2000/2006
2000
2006
5
Issues with non-cancer effects
  • Data is often descriptive/ subjective
  • Inconsistent diagnostic criteria
  • Data often presented without context
  • Data often presented without control groups
  • Data without dose estimate or dose response
  • Data often for only one country
  • Conclusions are less scientifically rigorous than
    the cancer data
  • Could not cover every claimed health effect

6
Various mechanisms for non-cancer health effects
Mental Health Psychological
Cancer
Radiation burns, cataracts
7
2003
2004
Ukraine
Russia
8
8 Major issues addressed by EGH-3
  • Cataracts
  • Cardiovascular diseases
  • Cytogenetic markers and significance
  • Immunological system effects
  • Heritable effects, birth defects, childrens
    health
  • Mental,psychological and nervous system effects
  • Mortality due to the accident
  • Medical programs and medical monitoring

9
Cataracts
  • Issues
  • - Cataracts do occur at high doses
  • - Trained observers. Coherent criteria
  • Consensus
  • Changes do occur at doses lower than in prior
    literature
  • Gaps
  • Is there a threshold ?
  • Actual doses to the lens (esp. beta)
  • Ultimate effect on visual function
  • Effect on ocular tissue other than the lens

10
Lens
Front
Back
Vano Worgul
11
(No Transcript)
12
Identifiable changes ? significance
13
Cataracts
  • Conclusion
  • Cataracts may occur at doses of 0.25 Gy
  • Recommendations
  • Continued follow-up of liquidators and radiation
    workers
  • Careful evaluation of doses to lens
  • Continue study of those already recruited
  • Ocular examination of general population probably
    unwarranted and wasteful

14
Cardiovascular diseases
  • Issues
  • High doses can cause cardiovascular disease
  • Complicated by smoking (more deaths than due to
    lung cancer), genetics and diet.
  • Possible relation in atomic bomb survivors
  • Consensus
  • Only data from Russian liquidators
  • Increase is not correlated with MI and ischemic
    heart disease
  • Gaps
  • Dose estimates vs cardiovascular disease
  • Lack of good control groups and small cohorts

15
Chernobyl ARS survivor and physicians
16
Cardiovascular diseases
  • Conclusion
  • ARS survivors are likely at increased risk
  • Russian liquidators show increased risk but this
    needs to be validated and further evaluated
  • Radiation effect not fully substantiated but
    small effect cannot be excluded
  • Recommendations
  • Validation studies of liquidators in other
    countries with control groups dosimetry, common
    diagnostic criteria and standardized protocols
  • Animal studies to investigate mechanisms

17
Cytogenetic markers
  • Issues
  • There are different markers in lymphocytes of the
    peripheral blood which persist for different
    times
  • Useful for biodosimetry (avarage bone marow dose)
  • Is there clinical significance ??
  • Micro and mini satellite data inconsistent
  • Consensus
  • FISH can detects doses as low as 0.25 Gy
  • None appear to result in direct damage that
    increases cancer or other health effects
  • Gaps
  • More studies to correlate markers with dose
  • Studies to directly correlate with markers and
    health in the same individuals

18
Chromosome analysis
Dicentric (stable)
Fragment (unstable)
19
FISH (fluorescent in-situ hybridization)Individua
l chromosome painting
20
Cytogenetic markers
  • Conclusion
  • No direct relationship shown with health or
    disease
  • Used for dose estimation and as a rough estimate
    of potential future risk from cancer
  • Recommendations
  • Correlation of biological dosimetry with
    epidemiology

21
Immunological effects
  • Issues
  • Very high doses of radiation can reduce immune
    function
  • Low doses of radiation may have laboratory
    findings but .? effect on discernable illness
  • Various studies are not coherent with regard to
    type and timing of findings
  • Consensus
  • Reported changes are in peripheral lymphocytes
    and remain detectable. The cause is not clear
    (diet, chemicals, chronic infections or radiation
  • Gaps
  • Role of confounding factors,

22
Immunological effects
  • Conclusions
  • There is significant variation in reported
    results and many are in conflict with the atomic
    bomb survivor literature
  • At doses of less than several tens of mSv, no
    clinical effects have been related to lymphocyte
    immune changes
  • Recommendations
  • -studies should continue after in persons with
    high absorbed doses.
  • -studies at doses at less than several 10s of
    mSv are unlikely to be of value
  • - studies on children with individual absorbed
    doses and control groups may be of value

23
Heritable, reproductive effects, childrens
health
  • Issues
  • Hereditary changes in human offspring not shown
    in the literature
  • Fertility. Permanent changes not likely at doses
    to the general population or many liquidators
    (below 0.2 Gy). Birth rate issues clouded by high
    medical abortion rate..
  • In-utero direct effects, malformations (not
    likely below 0.1-0.2 Gy).
  • Infant mortality rates
  • Consensus
  • No definite radiation effects. Infant mortality
  • high in the general population

24
Congenital malformations (9 defined types) in
Belarus
Low contamination
Lazjuk
25
Downs syndrome in Belarus
Zatsepin
26
(No Transcript)
27
Infant mortality (Ukraine)
28
Infant mortality in contaminated oblasts and
Ukraine as a whole
29
Infant mortality (Ukraine)
30
Heritable, reproductive effects, childrens
health
  • Gaps
  • Fundamental cause of high infant mortality
  • Conclusions
  • No clear radiation effects on fertility,
    malformations or infant mortality
  • No conclusion on adverse complications of
    pregnancy stillbirths etc
  • Reported decrease in health of children not
    related to radiation dose. Several possible
    causes
  • Hereditary effects not seen and very unlikely

31
Heritable, reproductive effects, childrens
health
  • Recommendations
  • Investigate basic causes of high infant mortality
    in clean and contaminated areas
  • As a public health measure, continue registers on
    reproductive health outcomes
  • Actions to reduce psychosocial measures for those
    exposed a s children
  • Discourage studies that do not provide baseline
    values, time period, estimates of absorbed dose,
    blinded evaluation and analysis etc.

32
Psychological, mental and nervous system effects
  • Issues
  • - ? In-utero mental retardation
  • ? Direct effects on the brain among highly
    exposed
  • Psychological consequences
  • Consensus
  • Psychological effects are the largest public
    health impact from the accident
  • May not be possible to disentangle accident
    effects from other stressors
  • High levels of anxiety and unexplained medical
    complaints continue up to the present

33
(No Transcript)
34
Psychological, mental and nervous system effects
  • Gaps
  • Few studies integrate mental and physical health
  • Systematic research on highly exposed workers
  • Adequate studies of children and adolescents
  • Best intervention to reduce level of anxiety
  • Conclusions
  • Serious mental health impact mainly at a
    sub-clinical level with implications for
    subjective health, reproductive health, medical
    service utilization
  • Need for timely and accurate information
    communication in disasters

35
Psychological, mental and nervous system effects
  • Recommendations
  • -Generate general public health policy due to
    high rates of psychiatric and substance disorders
    in population not limited to Chernobyl exposed
  • - Additional research on most highly exposed
    (ARS) for cognitive changes with imaging or
    pathological correlation
  • Accounting for psychological effect when
    conducting epidemiological studies of other
    health effects
  • Major increase mental health training for primary
    physicians and nurses
  • Move locus of care to primary care settings

36
Mortality due to the accident
  • Issues
  • Short term deaths (very well known)
  • Intermediate deaths (reasonably well known)
  • Long term (estimates)
  • Issues with major changes in lifespan due to
    unrelated causes
  • Data on liquidators (Russia), public (Ukraine)
  • Consensus
  • No detectable increase in general population,
    small increase in liquidators (but lower than in
    general population.

37
Major changes in lifespan over last 2 decades
even in non-contaminated areas complicate analysis
38
Chernobyl fireman
39
SMR all causes Russian liquidators vs. general
population (1991-98
Ivanov
40
SMR Non-cancer diseases Russian liquidators vs.
general population (1991-98)
Ivanov
41
Mortality of general population
42
(No Transcript)
43
Contaminated areas of Ukraine
16 vs 18.5 ? Age distribution difference
Korol
44
Mortality due to the accident
  • Conclusions
  • Acute 28 persons due to ARS 1986,
    2 in explosion
  • 134 ARS 1987-2004
    various reasons
  • Intermediate 216 excess (4.6 ,1991-1998)
    among Russian
  • workers but lower
    mortality than among general
  • population
  • - Long term 4,000 due to radiogenic
    cancer and leukemia
  • in 600,000 persons.
    Difficult to detect. More people at
    doses lt50 mSv, uncertain effect
  • Recommendations
  • - Continue liquidator mortality studies.
  • - Mortality studies of general population
    mortality are unlikely to
  • be useful relative to the accident due to
    low signal to noise ratio
  • and confounding. Useful general public
    health tool.

45
Medical programs and medical monitoring
  • Issues
  • Monitoring in place for liquidators, asymptomatic
    children and general public of contaminated
    territories
  • What is the beneficial effect vs. the cost/need
  • Consensus
  • Initial medial triage and ARS treatment saved
    many lives
  • Screening for many cancers or leukemia is not
    effective
  • Long term follow-up of asymptomatic persons who
    received low doses is not likely to provide any
    medical benefit
  • Need for monitoring of highly exposed and medical
    care for symptomatic individuals continues

46
Medical follow-up after high exposures
47
(No Transcript)
48
Medical programs and medical monitoring
  • Gaps
  • Which interventions were effective in highly
    exposed individuals
  • Effect of screening for thyroid cancer on
    outcomes
  • Conclusions
  • Continue medical monitoring of asymptomatic
    individuals may have a negative impact
  • Recommendations
  • Reevaluate cost/benefit of monitoring large
  • asymptomatic populations
  • Limited research on selected populations
  • Continue thyroid screening but evaluate
  • Continue on sensitive/high risk persons

49
Cancer screening
  • Cancer is the major direct health below 1 Gy
  • Some cancers are poorly or not radiogenic (e.g.
    prostate, uterine cervix, lymphoma)
  • Some do not have proven effective screening tests
    (e.g. leukemia, pancreas, lung)
  • Radiation levels to double risk of most solid
    cancers is above 1 Gy
  • If there is an effective cancer screening test,
    it should be used on the general public
    regardless of radiation exposure.

50
Risks of death in an exposed population (0.25 Sv)
Radiation excess deaths
Expected non-radiation cancer deaths
Non cancer deaths
51
Major conclusions
  • Cataracts possible lower doses-more research
  • Cardiovascular possible effect, more research
  • Cytogenetic markers. For dose/risk estimate. No
    direct health effect
  • Immunological. Confused conflicting laboratory
    data. No definite clinical effect. Research high
    dose liquidators.
  • Congenital malformations/ Infant mortality /
    childrens health. No definite increase due to
    radiation. General infant mortality high (general
    public health concern). Issues about
    psychological aspect of those exposed as children
    and adolescents

52
Major conclusions (contd)
  • Mortality- possibly thousands over time due to
    accident but hard to detect on current mortality
    background and changes. High in general
    population with significantly reduced lifespan
    over last decade
  • Psychological. Major issue continues. Need to get
    away from invalid concept. Look at interventions.
    Multiple stressors. Need overall look at overall
    mental health programs in light of substance
    abuse, suicide etc.
  • Medical follow-up/ screening. Medical follow-up
    of highly exposed should be continued. Screening
    for exposed populations should be reconsidered
    and may be better used for other general public
    health areas of concern.

53
A Joint Project of 8 UN Agencies
Additional material and detail in the actual
report. Please read it
54
(No Transcript)
Write a Comment
User Comments (0)
About PowerShow.com